Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Affordable, arose, beneficiary, Biden, Biopharma, Dizal, donut, esophageal, excise, gastric, GI, goal, hole, Huaota, Innolake, IRA, junction, macroeconomic, operationalized, outpace, people, ratio, revised, sublease, sublessee, subsidiary, titled, Topic, unclear, unfinished, updated, upper
Removed:
antitrust, CMC, missed, NaN, paramount, productivity, reclassify, return, utilize, vaccine, vision, waiting
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view